Illumina
Illumina launches its first product enabling long- and short-read sequencing on one instrument
2023-03-14
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
2022-11-17Partner
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115